Role of ACE2 in diastolic and systolic heart failure

Heart Failure Reviews

Volumn 17, Issue 4-5, 2012, Pages 683-691

  Wang, Wang ^a   Bodiga, Sreedhar ^a   Das, Subhash K ^a   Lo, Jennifer ^a   Patel, Vaibhav ^a   Oudit, Gavin Y ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Angiotensin 1 7; Angiotensin II; Angiotensin converting enzyme 2; Diastolic dysfunction; Heart failure; Hypertension

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; APELIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN MAS; RENIN INHIBITOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEART FAILURE; HEART PROTECTION; HUMAN; HYPERTENSION; NEGATIVE FEEDBACK; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SYSTOLIC HEART FAILURE; TISSUE DISTRIBUTION; VASCULAR DISEASE;

ANGIOTENSIN I; ANGIOTENSIN II; HEART FAILURE; HUMANS; HYPERTENSION; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84862648459     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9259-x     Document Type: Review

References (77)

1. MA Zaman S Oparil DA Calhoun 2002 Drugs targeting the renin-angiotensin-aldosterone system Nat Rev Drug Discov 1 621 636 12402502 10.1038/nrd873 1:CAS:528:DC%2BD38XlslGqtr0%3D
2. SR Tipnis NM Hooper R Hyde E Karran G Christie AJ Turner 2000 A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase J Biol Chem 275 33238 33243 10924499 10.1074/jbc.M002615200 1:CAS:528:DC%2BD3cXnvVOqtbw%3D
3. M Donoghue F Hsieh E Baronas K Godbout M Gosselin N Stagliano M Donovan B Woolf K Robison R Jeyaseelan RE Breitbart S Acton 2000 A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Circ Res 87 E1 E9 10969042 1:CAS:528: DC%2BD3MXhslOisr8%3D
4. MA Crackower R Sarao GY Oudit C Yagil I Kozieradzki SE Scanga AJ Oliveira-dos-Santos J da Costa L Zhang Y Pei J Scholey CM Ferrario AS Manoukian MC Chappell PH Backx Y Yagil JM Penninger 2002 Angiotensin-converting enzyme 2 is an essential regulator of heart function Nature 417 822 828 12075344 10.1038/nature00786 1:CAS:528:DC%2BD38Xks1Wmurg%3D
5. GY Oudit Z Kassiri MP Patel M Chappell J Butany PH Backx RG Tsushima JW Scholey R Khokha JM Penninger 2007 Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice Cardiovasc Res 75 29 39 17499227 10.1016/j.cardiores.2007.04.007 1:CAS:528:DC%2BD2sXmt1yntLc%3D
6. J Zhong R Basu D Guo FL Chow S Byrns M Schuster H Loibner XH Wang JM Penninger Z Kassiri GY Oudit 2010 Angiotensin converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and cardiac dysfunction Circulation 122 717 728 20679547 10.1161/CIRCULATIONAHA.110.955369 1:CAS:528:DC%2BC3cXhtVeksbrJ
7. Bodiga S, Zhong JC, Wang W, Basu R, Lo J, Liu GC, Guo D, Holland SM, Scholey JW, Penninger JM, Kassiri Z, Oudit GY (2011) Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit. Cardiovasc Res (in press)
8. F Lovren Y Pan A Quan H Teoh G Wang PC Shukla KS Levitt GY Oudit M Al-Omran DJ Stewart AS Slutsky MD Peterson PH Backx JM Penninger S Verma 2008 Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis Am J Physiol Heart Circ Physiol 295 H1377 H1384 18660448 10.1152/ajpheart.00331.2008 1:CAS:528:DC%2BD1cXht1ymtbbI
9. B Rentzsch M Todiras R Iliescu E Popova LA Campos ML Oliveira OC Baltatu RA Santos M Bader 2008 Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function Hypertension 52 967 973 18809792 10.1161/HYPERTENSIONAHA.108.114322 1:CAS:528:DC%2BD1cXht1GgtbvM
10. J Wysocki M Ye E Rodriguez FR González-Pacheco C Barrios K Evora M Schuster H Loibner KB Brosnihan CM Ferrario JM Penninger D Batlle 2009 Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension Hypertension 55 90 98 19948988 10.1161/HYPERTENSIONAHA.109.138420
11. GY Oudit AM Herzenberg Z Kassiri D Wong H Reich R Khokha MA Crackower PH Backx JM Penninger JW Scholey 2006 Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis Am J Pathol 168 1808 1820 16723697 10.2353/ajpath.2006.051091 1:CAS:528: DC%2BD28XlvVOhs7g%3D
12. GY Oudit GC Liu J Zhong R Basu FL Chow J Zhou H Loibner E Janzek M Schuster JM Penninger AM Herzenberg Z Kassiri JW Scholey 2010 Human recombinant ACE2 reduces the progression of diabetic nephropathy Diabetes 59 529 538 19934006 10.2337/db09-1218 1:CAS:528:DC%2BC3cXhvVyqsro%3D
13. J Zhong D Guo CB Chen W Wang M Schuster H Loibner JM Penninger JW Scholey Z Kassiri GY Oudit 2011 Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2 Hypertension 57 314 322 21189404 10.1161/HYPERTENSIONAHA.110.164244 1:CAS:528:DC%2BC3MXnvVWlsg%3D%3D
14. Y Ishiyama PE Gallagher DB Averill EA Tallant KB Brosnihan CM Ferrario 2004 Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors Hypertension 43 970 976 15007027 10.1161/01.HYP.0000124667.34652.1a 1:CAS:528:DC%2BD2cXjt1Gmsb4%3D
15. CM Ferrario J Jessup MC Chappell DB Averill KB Brosnihan EA Tallant DI Diz PE Gallagher 2005 Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 Circulation 111 2605 2610 15897343 10.1161/CIRCULATIONAHA.104.510461 1:CAS:528:DC%2BD2MXkt1Shsbk%3D
16. MP Ocaranza I Godoy JE Jalil M Varas P Collantes M Pinto M Roman C Ramirez M Copaja G Diaz-Araya P Castro S Lavandero 2006 Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat Hypertension 48 572 578 16908757 10.1161/01.HYP.0000237862.94083.45 1:CAS:528:DC%2BD28XpsFOrsr4%3D
17. JC Zhong JY Ye HY Jin X Yu HM Yu DL Zhu PJ Gao DY Huang M Shuster H Loibner JM Guo XY Yu BX Xiao ZH Gong JM Penninger GY Oudit 2011 Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression Regul Pept 166 90 97 20854846 10.1016/j.regpep.2010.09. 005 1:CAS:528:DC%2BC3cXhsF2jt7bE
18. C Vickers P Hales V Kaushik L Dick J Gavin J Tang K Godbout T Parsons E Baronas F Hsieh S Acton M Patane A Nichols P Tummino 2002 Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase J Biol Chem 277 14838 14843 11815627 10.1074/jbc.M200581200 1:CAS:528:DC%2BD38XjslSgsbo%3D
19. RA Santos AC Simoes e Silva C Maric DM Silva RP Machado I de Buhr S Heringer-Walther SV Pinheiro MT Lopes M Bader EP Mendes VS Lemos MJ Campagnole-Santos HP Schultheiss R Speth T Walther 2003 Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proc Natl Acad Sci USA 100 8258 8263 12829792 10.1073/pnas.1432869100 1:CAS:528:DC%2BD3sXlsFGnsbc%3D
20. C Mercure A Yogi GE Callera AB Aranha M Bader AJ Ferreira RA Santos T Walther RM Touyz TL Reudelhuber 2008 Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart Circ Res 103 1319 1326 18845809 10.1161/CIRCRESAHA.108.184911 1:CAS:528:DC%2BD1cXhtlKrt7fO
21. AJ Turner JA Hiscox NM Hooper 2004 ACE2: from vasopeptidase to SARS virus receptor Trends Pharmacol Sci 25 291 294 15165741 10.1016/j.tips.2004.04.001 1:CAS:528:DC%2BD2cXksVels7Y%3D
22. JL Guy RM Jackson KR Acharya ED Sturrock NM Hooper AJ Turner 2003 Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence Biochemistry 42 13185 13192 14609329 10.1021/bi035268s 1:CAS:528:DC%2BD3sXot1Kiu7g%3D
23. S Epelman K Shrestha RW Troughton GS Francis S Sen AL Klein WH Tang 2009 Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes J Card Fail 15 565 571 19700132 10.1016/j.cardfail.2009.01.014 1:CAS:528:DC%2BD1MXhtVehurrI
24. DW Lambert M Yarski FJ Warner P Thornhill ET Parkin AI Smith NM Hooper AJ Turner 2005 Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2) J Biol Chem 80 30113 301139 10.1074/jbc.M505111200
25. PJ Garabelli JG Modrall JM Penninger CM Ferrario MC Chappell 2008 Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart Exp Physiol 93 613 621 18356559 10.1113/expphysiol.2007.040246 1:CAS:528:DC%2BD1cXnvFChtLs%3D
26. Z Kassiri J Zhong D Guo R Basu X Wang PP Liu JW Scholey JM Penninger GY Oudit 2009 Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction Circ Heart Fail 2 446 455 19808375 10.1161/CIRCHEARTFAILURE.108.840124 1:CAS:528: DC%2BD1MXhtV2qs73P
27. RA Santos AJ Ferreira SV Pinheiro WO Sampaio R Touyz MJ Campagnole-Santos 2005 Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs Expert Opin Investig Drugs 14 1019 1031 16050794 10.1517/13543784.14.8.1019 1:CAS:528:DC%2BD2MXmvFelsr8%3D
28. DK Lee R Cheng T Nguyen T Fan AP Kariyawasam Y Liu DH Osmond SR George BF O'Dowd 2000 Characterization of apelin, the ligand for the APJ receptor J Neurochem 74 34 41 10617103 10.1046/j.1471-4159.2000.0740034.x 1:CAS:528:DC%2BD3cXlt1Oi
29. SL Pitkin JJ Maguire TI Bonner AP Davenport 2010 International union of basic and clinical pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function Pharmacol Rev 62 331 342 20605969 10.1124/pr.110.002949 1:CAS:528:DC%2BC3cXhsVSltbbO
30. PE Gallagher CM Ferrario EA Tallant 2008 Regulation of ACE2 in cardiac myocytes and fibroblasts Am J Physiol Heart Circ Physiol 295 H2373 H2379 18849338 10.1152/ajpheart.00426.2008 1:CAS:528:DC%2BD1cXhsFSntbrL
31. AB Goulter MJ Goddard JC Allen KL Clark 2004 ACE2 gene expression is up-regulated in the human failing heart BMC Med 2 19 15151696 10.1186/1741-7015-2-19
32. LM Burrell J Risvanis E Kubota RG Dean PS MacDonald S Lu C Tikellis SL Grant RA Lew AI Smith ME Cooper CI Johnston 2005 Myocardial infarction increases ACE2 expression in rat and humans Eur Heart J 26 369 375 15671045 10.1093/eurheartj/ehi114 1:CAS:528:DC%2BD2MXksFGgu7Y%3D
33. SB Gurley A Allred TH Le R Griffiths L Mao N Philip TA Haystead M Donoghue RE Breitbart SL Acton HA Rockman TM Coffman 2006 Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice J Clin Invest 116 2218 2225 16878172 10.1172/JCI16980 1:CAS:528:DC%2BD28XnvF2mt7g%3D
34. K Yamamoto M Ohishi T Katsuya N Ito M Ikushima M Kaibe Y Tatara A Shiota S Sugano S Takeda H Rakugi T Ogihara 2006 Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II Hypertension 47 718 726 16505206 10.1161/01.HYP. 0000205833.89478.5b 1:CAS:528:DC%2BD28XitlSgtLc%3D
35. W Lieb J Graf A Götz IR König B Mayer M Fischer J Stritzke C Hengstenberg SR Holmer A Döring H Löwel H Schunkert J Erdmann 2006 Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy J Mol Med 84 88 96 16283142 10.1007/s00109-005-0718-5 1:CAS:528:DC%2BD28XksVOlsw%3D%3D
36. W Yang W Huang S Su B Li W Zhao S Chen D Gu 2006 Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population Clin Sci (Lond) 111 333 340 10.1042/CS20060020 1:CAS:528:DC%2BD28XhtVOis7vJ
37. J Zhong Z Yan D Liu Y Ni Z Zhao S Zhu M Tepel Z Zhu 2006 Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome J Lab Clin Med 147 91 95 16459167 10.1016/j.lab.2005.10.001 1:CAS:528:DC%2BD28XhtFShu70%3D
38. YX Zhao HQ Yin QT Yu Y Qiao HY Dai MX Zhang L Zhang YF Liu LC Wang S de Liu BP Deng YH Zhang CM Pan HD Song X Qu H Jiang CX Liu XT Lu B Liu F Gao B Dong 2010 ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction Hum Gene Ther 21 1545 1554 20507236 10.1089/hum.2009.160 1:CAS:528:DC%2BC3cXhsVCrsLjP
39. JL Grobe S Der Sarkissian JM Stewart JG Meszaros MK Raizada MJ Katovich 2007 ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts Clin Sci (Lond) 113 357 364 10.1042/CS20070160 1:CAS:528: DC%2BD2sXhtVeisLvM
40. Y Wang C Moreira Mda S Heringer-Walther L Ebermann HP Schultheiss N Wessel WE Siems T Walther 2010 Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP J Card Fail 16 157 163 20142028 10.1016/j.cardfail.2009.09.005
41. X Xie J Chen X Wang F Zhang Y Liu 2006 Age- and gender-related difference of ACE2 expression in rat lung Life Sci 78 2166 2171 16303146 10.1016/j.lfs.2005.09.038 1:CAS:528:DC%2BD28XivVOgsL8%3D
42. BI Jugdutt 2010 Aging and heart failure: changing demographics and implications for therapy in the elderly Heart Fail Rev 15 401 405 20364319 10.1007/s10741-010-9164-8
43. A Jelani BI Jugdutt 2010 STEMI and heart failure in the elderly: role of adverse remodeling Heart Fail Rev 15 513 521 20549342 10.1007/s10741-010-9177-3
44. RS Bhatia JV Tu DS Lee PC Austin J Fang A Haouzi Y Gong PP Liu 2006 Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 260 269 16855266 10.1056/NEJMoa051530 1:CAS:528:DC%2BD28XntVWktro%3D
45. TE Owan DO Hodge RM Herges SJ Jacobsen VL Roger MM Redfield 2006 Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 251 259 16855265 10.1056/NEJMoa052256 1:CAS:528: DC%2BD28XntVWktr0%3D
46. MR Zile DL Brutsaert 2002 New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment Circulation 105 1503 1508 11914262 10.1161/hc1202.105290
47. M Iwata RT Cowling D Gurantz C Moore S Zhang JX Yuan BH Greenberg 2005 Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects Am J Physiol Heart Circ Physiol 289 H2356 H2363 16024575 10.1152/ajpheart.00317.2005 1:CAS:528:DC%2BD28XlslGnsA%3D%3D
48. KT Weber CG Brilla 1991 Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system Circulation 83 1849 1865 1828192 1:STN:280:DyaK3M3kvFChtg%3D%3D
49. MJ Huentelman JL Grobe J Vazquez JM Stewart AP Mecca MJ Katovich CM Ferrario MK Raizada 2005 Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats Exp Physiol 90 783 790 16049057 10.1113/expphysiol.2005.031096 1:CAS:528: DC%2BD2MXhtFKkt7zI
50. CC Wei N Hase Y Inoue EW Bradley E Yahiro M Li N Naqvi PC Powell K Shi Y Takahashi K Saku H Urata LJ Dell'italia A Husain 2010 Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents J Clin Invest 120 1229 1239 20335663 10.1172/JCI39345 1:CAS:528: DC%2BC3cXksVChsb0%3D
51. OA Carretero S Oparil 2000 Essential hypertension. Part I: definition and etiology Circulation 101 329 335 10645931 1:STN:280:DC%2BD3c7ht1OgsQ%3D%3D
52. M Stoll HJ Jacob 2001 Genetic rat models of hypertension: relationship to human hypertension Curr Hypertens Rep 3 157 164 11276399 10.1007/s11906-001- 0031-9 1:STN:280:DC%2BD3M7ovVWntg%3D%3D
53. GY Oudit MA Crackower PH Backx JM Penninger 2003 The role of ACE2 in cardiovascular physiology Trends Cardiovasc Med 13 93 101 12691672 10.1016/S1050-1738(02)00233-5 1:CAS:528:DC%2BD3sXis12ks7w%3D
54. M Yamazato Y Yamazato C Sun C Diez-Freire MK Raizada 2007 Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats Hypertension 49 926 931 17325232 10.1161/01.HYP.0000259942.38108.20 1:CAS:528:DC%2BD2sXivVamt7o%3D
55. Y Feng H Xia Y Cai CM Halabi LK Becker RA Santos RC Speth CD Sigmund E Lazartigues 2010 Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension Circ Res 106 373 382 19926873 10.1161/CIRCRESAHA.109.208645 1:CAS:528:DC%2BC3cXhsVyhtLw%3D
56. MC Thomas RJ Pickering D Tsorotes A Koitka K Sheehy S Bernardi B Toffoli TP Nguyen-Huu GA Head Y Fu J Chin-Dusting ME Cooper C Tikellis 2010 Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse Circ Res 107 888 897 20671240 10.1161/CIRCRESAHA.110.219279 1:CAS:528:DC%2BC3cXht1Gku7jK
57. C Zhang YX Zhao YH Zhang L Zhu BP Deng ZL Zhou SY Li XT Lu LL Song XM Lei WB Tang N Wang CM Pan HD Song CX Liu B Dong Y Zhang Y Cao 2010 Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells Proc Natl Acad Sci USA 107 15886 15891 20798044 10.1073/pnas.1001253107 1:CAS:528:DC%2BC3cXhtFOqtLbP
58. LS Zisman GE Meixell MR Bristow CC Canver 2003 Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate Circulation 108 1679 1681 14504185 10.1161/01.CIR.0000094733.61689.D4 1:CAS:528:DC%2BD3sXns1Cgu7s%3D
59. LS Zisman RS Keller B Weaver Q Lin R Speth MR Bristow CC Canver 2003 Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2 Circulation 108 1707 1712 14504186 10.1161/01.CIR.0000094734.67990.99 1:CAS:528:DC%2BD3sXns1Cgu70%3D
60. DJ Campbell CJ Zeitz MD Esler JD Horowitz 2004 Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation J Hypertens 22 1971 1976 15361769 10.1097/00004872-200410000-00020 1:CAS:528: DC%2BD2cXnsV2kt7s%3D
61. KB Brosnihan P Li EA Tallant CM Ferrario 1998 Angiotensin-(1-7): a novel vasodilator of the coronary circulation Biol Res 31 227 234 9830510 1:STN:280:DyaK1M%2FkvVajsA%3D%3D
62. HL Jackman MG Massad M Sekosan F Tan V Brovkovych BM Marcic EG Erdös 2002 Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A Hypertension 39 976 981 12019279 10.1161/01.HYP.0000017283.67962.02 1:CAS:528:DC%2BD38Xkt1agtrc%3D
63. Y Ren JL Garvin OA Carretero 2002 Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles Hypertension 39 799 802 11897767 10.1161/hy0302.104673 1:CAS:528:DC%2BD38XisVegt7g%3D
64. JL Grobe AP Mecca M Lingis V Shenoy TA Bolton JM Machado RC Speth MK Raizada MJ Katovich 2007 Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7) Am J Physiol Heart Circ Physiol 292 H736 H742 17098828 10.1152/ajpheart.00937.2006 1:CAS:528:DC%2BD2sXjt1Gns7s%3D
65. Y Wang C Qian AJ Roks D Westermann SM Schumacher F Escher RG Schoemaker TL Reudelhuber WH van Gilst HP Schultheiss C Tschöpe T Walther 2010 Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction Circ Heart Fail 3 286 293 20103774 10.1161/CIRCHEARTFAILURE.109.905968 1:CAS:528:DC%2BC3cXlsVSjsLs%3D
66. WC De Mello CM Ferrario JA Jessup 2007 Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart J Renin Angiotensin Aldosterone Syst 8 74 80 17703433 10.3317/jraas.2007.015
67. E Kostenis G Milligan A Christopoulos CF Sanchez-Ferrer S Heringer-Walther PM Sexton F Gembardt E Kellett L Martini P Vanderheyden HP Schultheiss T Walther 2005 G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor Circulation 111 1806 1813 15809376 10.1161/01.CIR.0000160867.23556.7D 1:CAS:528:DC%2BD2MXivFelur4%3D
68. H Urata B Healy RW Stewart FM Bumpus A Husain 1990 Angiotensin II-forming pathways in normal and failing human hearts Circ Res 66 883 890 2156635 1:CAS:528:DyaK3cXktVequ7Y%3D
69. H Urata A Kinoshita KS Misono FM Bumpus A Husain 1990 Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart J Biol Chem 265 22348 22357 2266130 1:CAS:528:DyaK3MXhtFOgtbo%3D
70. DE Jenne J Tschopp 1991 Angiotensin II-forming heart chymase is a mast-cell-specific enzyme Biochem J 276 567 568 2049082 1:CAS:528: DyaK3MXkt1GjtrY%3D
71. CJ Mackins S Kano N Seyedi U Schäfer AC Reid T Machida RB Silver R Levi 2006 Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion J Clin Invest 116 1063 1070 16585966 10.1172/JCI25713 1:CAS:528:DC%2BD28XjsVWnur0%3D
72. M Hara K Ono MW Hwang A Iwasaki M Okada K Nakatani S Sasayama A Matsumori 2002 Evidence for a role of mast cells in the evolution to congestive heart failure J Exp Med 195 375 381 11828013 10.1084/jem.20002036 1:CAS:528: DC%2BD38Xht1WjtL4%3D
73. L Juillerat J Nussberger J Ménard V Mooser Y Christen B Waeber P Graf HR Brunner 1990 Determinants of angiotensin II generation during converting enzyme inhibition Hypertension 16 564 572 2172161 1:CAS:528:DyaK3MXitVSgtrw%3D
74. RM van de Wal HW Plokker DJ Lok F Boomsma FA van der Horst DJ van Veldhuisen WH van Gilst AA Voors 2006 Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition Int J Cardiol 106 367 372 16337046 10.1016/j.ijcard.2005.02.016
75. E Roig F Perez-Villa M Morales W Jiménez J Orús M Heras G Sanz 2000 Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure Eur Heart J 21 53 57 10610744 10.1053/euhj.1999.1740 1:CAS:528:DC%2BD3cXpt1ygtQ%3D%3D
76. G Wiemer LW Dobrucki FR Louka T Malinski H Heitsch 2002 AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium Hypertension 40 847 852 12468568 10.1161/01.HYP.0000037979.53963.8F 1:CAS:528:DC%2BD38XovFKgu7Y%3D
77. JA Hernández Prada AJ Ferreira MJ Katovich V Shenoy Y Qi RA Santos RK Castellano AJ Lampkins V Gubala DA Ostrov MK Raizada 2008 Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents Hypertension 51 1312 1317 18391097 10.1161/HYPERTENSIONAHA.107.108944